Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2008
12/31/2008WO2009003125A1 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
12/31/2008WO2009003073A1 Article comprising calcium for reducing the production of tsst-1
12/31/2008WO2009002935A1 Transdermal delivery system comprising glycopyrrolate to treat sialorrhea
12/31/2008WO2009002874A1 Formation of stable submicron peptide or protein particles by thin film freezing
12/31/2008WO2009002867A2 Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
12/31/2008WO2009002846A1 Laser marked dosage forms
12/31/2008WO2009002829A2 Tableted compositions containing atazanavir
12/31/2008WO2009002826A2 Tableted compositions containing atazanavir
12/31/2008WO2009002823A2 Tableted compositions containing atazanavir
12/31/2008WO2009002821A2 Tableted compositions containing atazanavir
12/31/2008WO2009002521A2 Compositions of specific binding agents to hepatocyte growth factor
12/31/2008WO2009002490A2 Formulations of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide
12/31/2008WO2009002416A1 Controlled release tamsulosin hydrochloride formulation
12/31/2008WO2009002274A1 Cationic peptide for delivering an agent into a cell
12/31/2008WO2009002084A2 Method for preparing rapidly disintegrating formulation for oral administration and apparatus for preparing and packing the same
12/31/2008WO2009001899A1 Aqueous composition
12/31/2008WO2009001884A1 Oxidized glutathione tablet
12/31/2008WO2009001786A1 Composition containing physiologically active substance
12/31/2008WO2009001697A2 Microspheres having core/shell structure
12/31/2008WO2009001591A1 Transdermal absorption type patch
12/31/2008WO2009001396A1 Disposable sterile ocular solution for corneal cross- linking of cheratocone, and process for production thereof
12/31/2008WO2009001163A1 Lyophilized preparations of pantoprazole sodium for injection
12/31/2008WO2009001146A1 Pharmaceutical composition containing acetylcholine esterase inhibitor and method for the preparation thereof
12/31/2008WO2009001144A2 Pharmaceutical aerosol compositions comprising fluticasone
12/31/2008WO2009001099A2 A pharmaceutical composition comprising polyaphron dispersion
12/31/2008WO2009001092A1 A bioerodible patch
12/31/2008WO2009001085A2 An inhalable composition comprising nicotine
12/31/2008WO2009001064A1 A novel powder and its method of manufacture
12/31/2008WO2009001043A2 Duloxetine formulation
12/31/2008WO2009001019A2 Nanocapsules with liquid lipidic core loaded with water-soluble or water-dispersible ingredient(s)
12/31/2008WO2009000955A1 Microparticles of alginate modified with rgd as a release system for medicines
12/31/2008WO2009000853A2 Combination formulations comprising darunavir and etravirine
12/31/2008WO2009000796A1 Disperse base material
12/31/2008WO2009000493A1 Method for the production of a medicament containing tadalafil
12/31/2008WO2009000478A1 Conveying device
12/31/2008WO2009000473A2 Effervescent tablets for inhalatory use
12/31/2008WO2009000433A1 Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
12/31/2008WO2009000286A1 Improved pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof
12/31/2008WO2009000262A1 Electrophoretic transdermal application system
12/31/2008WO2009000216A2 A rupturing controlled release device comprising a subcoat
12/31/2008WO2009000149A1 Use of notoginsenoside r1 in the preparation of the medicament for treating hepatic injuries
12/31/2008WO2009000146A1 Succinic acid-(5-androsten-17-one-3beta-ol)-diester solid dispersion, method for the production and the use thereof
12/31/2008WO2009000145A1 Use and preparation of paeoniflorin and the composition thereof
12/31/2008WO2009000132A1 Immediate release effervescent-formulation and preparing process thereof
12/31/2008WO2008140507A3 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
12/31/2008WO2008136705A3 Drugs for treating and preventing benign prostatic hyperplasia, prostatitis, impotency, infertility and prostate cancer and a method for the use thereof
12/31/2008WO2008133731A3 Rapidly disintegrating low friability tablets comprising silica materials
12/31/2008WO2008109806A3 Electrostatic coating of particles for drug delivery
12/31/2008WO2008099742A3 Ejection liquid and ejection method
12/31/2008WO2008086400A3 Sirtuin-activating compounds of enhanced bioavailability
12/31/2008WO2008073388A3 Alfuzosin formulations, methods of making and methods of use
12/31/2008WO2008068777A3 Stable lercanidipine formulation
12/31/2008WO2008068727A3 Pharmaceutical composition comprising candesartan cilexetil
12/31/2008WO2008067060A8 Formulations for treatment of adipose tissue, cutaneous tissue and disorders, and muscular tissue
12/31/2008WO2008063323A3 Treatment with antiarrhythmics and omega-3 fatty acids and a combination product thereof
12/31/2008WO2008045009A3 Pharmaceutical dosage form
12/31/2008WO2008037421A3 Pharmaceutical compositions comprising an s1p modulator
12/31/2008WO2008013955A3 Sustained release formulations for pulmonary delivery
12/31/2008WO2007144902A8 Chewable bilayer tablet formulation
12/31/2008WO2007132022A8 Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
12/31/2008WO2007075801A3 Method and system for the delivery of corticosteroids having an enhanced pharmacokinetic profile
12/31/2008WO2007044026A3 Compositions comprising modified collagen and uses therefore
12/31/2008WO2006099137A9 Endothelial predecessor cell seeded wound healing scaffold
12/31/2008EP2008710A1 Process and apparatus for producing liposome dispersion
12/31/2008EP2008708A2 Liquid solubilizers containing ethoxylated fatty alcohol and ethoxylated triglycerides
12/31/2008EP2008663A1 Liquid composition for external application and preparation for external application for treatment of skin ulcer
12/31/2008EP2008659A1 Liquid pharmaceutical formulations of palonosetron
12/31/2008EP2008651A1 A bioerodible patch
12/31/2008EP2008650A2 Solid oral composition comprising a S 1 P receptor agonist and a sugar alcohol
12/31/2008EP2008649A1 Spill resistant pharmaceutical compositions
12/31/2008EP2008581A2 Patient monitoring, diagnosis, and/or therapy systems and methods
12/31/2008EP2008532A1 Method for production of capsinoid-containing beverage/food
12/31/2008EP2007398A2 High delivery rates for lipid based drug formulations, and methods of treatment thereof
12/31/2008EP2007389A2 Compositions and methods for enhancing analgesic potency of covalently bound compounds, attenuating its adverse side effects, and preventing their abuse
12/31/2008EP2007384A1 Orodispersible domperidone tablets
12/31/2008EP2007367A1 Medicated feed premix comprising chlortetracycline hydrochloride
12/31/2008EP2007362A2 Oral dosage forms including an antiplatelet agent and an acid inhibitor
12/31/2008EP2007361A1 Film-coated solid dosage forms
12/31/2008EP2007360A1 Controlled release delivery device comprising an organosol coat
12/31/2008EP2007359A2 Dosage forms having a randomized coating
12/31/2008EP2007358A2 Swellable particles for drug delivery
12/31/2008EP2007357A2 Compositions of less immunogenic and long-circulating protein-lipid complexes
12/31/2008EP2007356A1 Lipoplex formulations for specific delivery to vascular endothelium
12/31/2008EP2007355A2 Liposomal compositions
12/31/2008EP2007354A1 Brimonidine and timolol compositions
12/31/2008EP2007353A2 Drug depot implant designs and methods of implantation
12/31/2008EP2007352A1 Treatment of psychiatric patients with sleep disturbances an/or excessive daytime sleepiness with paliperidone
12/31/2008EP2007351A2 Polymeric materials as stomach filler and their preparation
12/31/2008EP2007350A2 Degradable therapeutic delivery device
12/31/2008EP2007349A1 Aerosol suspension formulations comprising tg 227 ea or tg 134 a as propellants
12/31/2008EP2007348A1 Paediatric amino acid solution for parenteral nutrition
12/31/2008EP2007347A2 Composition comprising an agent for stabilizing active substances in drinking water, effervescent mixture, method for the production thereof, and use thereof
12/31/2008EP2007346A1 Osmotic dosage form
12/31/2008EP2007224A2 Emulsions and microcapsules with substances having low interfacial tension, methods of making and using thereof
12/31/2008EP2007197A1 Adherence-aided therapeutic horse hoof packing
12/31/2008EP2007196A2 Bone graft composition
12/31/2008EP1928431B1 Controlled release pharmaceutical composition containing carvedilol
12/31/2008EP1845947B1 Fast-disintegrating microporous binder and process for making it
12/31/2008EP1838283B1 Lipid-based drug delivery systems containing unnatural phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof
12/31/2008EP1809237B1 Ophthalmic oil-in-water type emulsion with stable positive zeta potential
1 ... 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 ... 2991